Neurosurgical Clinical Trials for Glioblastoma: Current and Future Directions

Overview

Journal Brain Sci

Publisher MDPI

Date 2022 Jun 24

PMID 35741672

Authors

Ashish H Shah

John D Heiss

Affiliations

Soon will be listed here.

Abstract

The mainstays of glioblastoma treatment, maximal safe resection, radiotherapy preserving neurological function, and temozolomide (TMZ) chemotherapy have not changed for the past 17 years despite significant advances in the understanding of the genetics and molecular biology of glioblastoma. This review highlights the neurosurgical foundation for glioblastoma therapy. Here, we review the neurosurgeon's role in several new and clinically-approved treatments for glioblastoma. We describe delivery techniques such as blood-brain barrier disruption and convection-enhanced delivery (CED) that may be used to deliver therapeutic agents to tumor tissue in higher concentrations than oral or intravenous delivery. We mention pivotal clinical trials of immunotherapy for glioblastoma and explain their outcomes. Finally, we take a glimpse at ongoing clinical trials and promising translational studies to predict ways that new therapies may improve the prognosis of patients with glioblastoma.

Citing Articles

Glioblastoma Therapy: Past, Present and Future.

Obrador E, Moreno-Murciano P, Oriol-Caballo M, Lopez-Blanch R, Pineda B, Gutierrez-Arroyo J Int J Mol Sci. 2024; 25(5).

PMID: 38473776 PMC: 10931797. DOI: 10.3390/ijms25052529.

RMTF-Net: Residual Mix Transformer Fusion Net for 2D Brain Tumor Segmentation.

Gai D, Zhang J, Xiao Y, Min W, Zhong Y, Zhong Y Brain Sci. 2022; 12(9).

PMID: 36138880 PMC: 9497369. DOI: 10.3390/brainsci12091145.

References

Jelsma R, Bucy P . Glioblastoma multiforme: its treatment and some factors effecting survival. Arch Neurol. 1969; 20(2):161-71. DOI: 10.1001/archneur.1969.00480080061007. View

Li Y, Suki D, Hess K, Sawaya R . The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?. J Neurosurg. 2015; 124(4):977-88. DOI: 10.3171/2015.5.JNS142087. View

Stupp R, Taillibert S, Kanner A, Kesari S, Steinberg D, Toms S . Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. JAMA. 2015; 314(23):2535-43. DOI: 10.1001/jama.2015.16669. View

Karabeber H, Huang R, Iacono P, Samii J, Pitter K, Holland E . Guiding brain tumor resection using surface-enhanced Raman scattering nanoparticles and a hand-held Raman scanner. ACS Nano. 2014; 8(10):9755-66. PMC: 4212801. DOI: 10.1021/nn503948b. View

Hollon T, Pandian B, Adapa A, Urias E, Save A, Khalsa S . Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks. Nat Med. 2020; 26(1):52-58. PMC: 6960329. DOI: 10.1038/s41591-019-0715-9. View

Tanglay O, Young I, Dadario N, Taylor H, Nicholas P, Doyen S . Eigenvector PageRank difference as a measure to reveal topological characteristics of the brain connectome for neurosurgery. J Neurooncol. 2022; 157(1):49-61. DOI: 10.1007/s11060-021-03935-z. View

Friedman G, Johnston J, Bag A, Bernstock J, Li R, Aban I . Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas. N Engl J Med. 2021; 384(17):1613-1622. PMC: 8284840. DOI: 10.1056/NEJMoa2024947. View

Di L, Wang C, Shah A, Eichberg D, Semonche A, Sanjurjo A . A Cohort Study on Prognostic Factors for Laser Interstitial Thermal Therapy Success in Newly Diagnosed Glioblastoma. Neurosurgery. 2021; 89(3):496-503. PMC: 8364818. DOI: 10.1093/neuros/nyab193. View

Vogelbaum M, Brewer C, Barnett G, Mohammadi A, Peereboom D, Ahluwalia M . First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1. J Neurosurg. 2018; 130(2):476-485. DOI: 10.3171/2017.10.JNS171845. View

10.

Stummer W, Pichlmeier U, Meinel T, Wiestler O, Zanella F, Reulen H . Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006; 7(5):392-401. DOI: 10.1016/S1470-2045(06)70665-9. View

11.

Eyupoglu I, Hore N, Fan Z, Buslei R, Merkel A, Buchfelder M . Intraoperative vascular DIVA surgery reveals angiogenic hotspots in tumor zones of malignant gliomas. Sci Rep. 2015; 5:7958. PMC: 4302292. DOI: 10.1038/srep07958. View

12.

Salehi A, Paturu M, Patel B, Cain M, Mahlokozera T, Yang A . Therapeutic enhancement of blood-brain and blood-tumor barriers permeability by laser interstitial thermal therapy. Neurooncol Adv. 2020; 2(1):vdaa071. PMC: 7344247. DOI: 10.1093/noajnl/vdaa071. View

13.

Lee I, Kalkanis S, Hadjipanayis C . Stereotactic Laser Interstitial Thermal Therapy for Recurrent High-Grade Gliomas. Neurosurgery. 2016; 79 Suppl 1:S24-S34. DOI: 10.1227/NEU.0000000000001443. View

14.

Kuo Y, Lee C . Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier. Colloids Surf B Biointerfaces. 2011; 90:75-82. DOI: 10.1016/j.colsurfb.2011.09.048. View

15.

Johnson L, Scholler J, Ohkuri T, Kosaka A, Patel P, McGettigan S . Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma. Sci Transl Med. 2015; 7(275):275ra22. PMC: 4467166. DOI: 10.1126/scitranslmed.aaa4963. View

16.

Shah A, Burks J, Buttrick S, Debs L, Ivan M, Komotar R . Laser Interstitial Thermal Therapy as a Primary Treatment for Deep Inaccessible Gliomas. Neurosurgery. 2018; 84(3):768-777. DOI: 10.1093/neuros/nyy238. View

17.

Reardon D, Brandes A, Omuro A, Mulholland P, Lim M, Wick A . Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2020; 6(7):1003-1010. PMC: 7243167. DOI: 10.1001/jamaoncol.2020.1024. View

18.

Ji M, Orringer D, Freudiger C, Ramkissoon S, Liu X, Lau D . Rapid, label-free detection of brain tumors with stimulated Raman scattering microscopy. Sci Transl Med. 2013; 5(201):201ra119. PMC: 3806096. DOI: 10.1126/scitranslmed.3005954. View

19.

Brown T, Shah A, Bregy A, Shah N, Thambuswamy M, Barbarite E . Awake craniotomy for brain tumor resection: the rule rather than the exception?. J Neurosurg Anesthesiol. 2013; 25(3):240-7. DOI: 10.1097/ANA.0b013e318290c230. View

20.

Laspidea V, Puigdelloses M, Labiano S, Marrodan L, Garcia-Moure M, Zalacain M . Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas. JCI Insight. 2022; 7(7). PMC: 9057625. DOI: 10.1172/jci.insight.154812. View